Correlation Between Santen Pharmaceutical and Grifols SA
Can any of the company-specific risk be diversified away by investing in both Santen Pharmaceutical and Grifols SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santen Pharmaceutical and Grifols SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Santen Pharmaceutical Co and Grifols SA ADR, you can compare the effects of market volatilities on Santen Pharmaceutical and Grifols SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santen Pharmaceutical with a short position of Grifols SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santen Pharmaceutical and Grifols SA.
Diversification Opportunities for Santen Pharmaceutical and Grifols SA
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Santen and Grifols is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Santen Pharmaceutical Co and Grifols SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grifols SA ADR and Santen Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santen Pharmaceutical Co are associated (or correlated) with Grifols SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grifols SA ADR has no effect on the direction of Santen Pharmaceutical i.e., Santen Pharmaceutical and Grifols SA go up and down completely randomly.
Pair Corralation between Santen Pharmaceutical and Grifols SA
Assuming the 90 days horizon Santen Pharmaceutical Co is expected to under-perform the Grifols SA. But the pink sheet apears to be less risky and, when comparing its historical volatility, Santen Pharmaceutical Co is 1.49 times less risky than Grifols SA. The pink sheet trades about -0.3 of its potential returns per unit of risk. The Grifols SA ADR is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 877.00 in Grifols SA ADR on August 31, 2024 and sell it today you would lose (70.00) from holding Grifols SA ADR or give up 7.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Santen Pharmaceutical Co vs. Grifols SA ADR
Performance |
| Timeline |
| Santen Pharmaceutical |
| Grifols SA ADR |
Santen Pharmaceutical and Grifols SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Santen Pharmaceutical and Grifols SA
The main advantage of trading using opposite Santen Pharmaceutical and Grifols SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santen Pharmaceutical position performs unexpectedly, Grifols SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grifols SA will offset losses from the drop in Grifols SA's long position.| Santen Pharmaceutical vs. Sanofi ADR | Santen Pharmaceutical vs. Bristol Myers Squibb | Santen Pharmaceutical vs. AstraZeneca PLC ADR | Santen Pharmaceutical vs. Gilead Sciences |
| Grifols SA vs. Novartis AG ADR | Grifols SA vs. AstraZeneca PLC ADR | Grifols SA vs. GlaxoSmithKline PLC ADR | Grifols SA vs. Roche Holding Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets |